NAGE

Niagen Bioscience Inc (NAGE)

Healthcare • NASDAQ$3.21+1.90%

Key Fundamentals
Symbol
NAGE
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$3.21
Daily Change
+1.90%
Market Cap
$238.96M
Trailing P/E
15.89
Forward P/E
30.20
52W High
$10.52
52W Low
$2.87
Analyst Target
$12.08
Dividend Yield
N/A
Beta
2.10
About Niagen Bioscience Inc

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU N

Company website

Research NAGE on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...